Steve Schonfeld’s Vor Biopharma VOR Stock Holding History

Steve Schonfeld’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-671	Closed	-$9.63K	–	2580
2025 Q1	$9.63K	Buy	+671	New	+$16.1K	﹤0.01%	2120

Other funds holding VOR

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Steve Schonfeld's VOR Position: Q2 2025 in Review

Steve Schonfeld sold out of Vor Biopharma (VOR) in Q2 2025, closing a stake of 671 shares — an estimated $9.63K sold.

Steve Schonfeld first reported a position in VOR in Q1 2025 and held it in 1 quarter. The position peaked at $9.63K in Q1 2025. 35 funds tracked by Wall St. Rank hold VOR as of Q2 2025.

Steve Schonfeld reported no remaining Vor Biopharma position as of Q2 2025 after selling out during the quarter.
Steve Schonfeld sold 671 Vor Biopharma shares in Q2 2025, an estimated $9.63K.
Steve Schonfeld first reported a position in Vor Biopharma in Q1 2025 and held it in 1 quarter.
Steve Schonfeld's Vor Biopharma position peaked at $9.63K in Q1 2025.
35 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.